{"date":"2026-06-10","count":32,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4745-2026-06-10-2034-i9b3f2","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-10","time":"20:34:49","subject":"(補充115/03/02公告)代重要子公司合富（中國）醫療科技股份有限公司公告民事訴訟相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-06-10 20:34，「(補充115/03/02公告)代重要子公司合富（中國）醫療科技股份有限公司公告民事訴訟相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-06-10-1944-sqgrt0","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-06-10","time":"19:44:51","subject":"公告本公司法人董事代表人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-06-10 19:44，「公告本公司法人董事代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-06-10-1914-ahj79a","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-06-10","time":"19:14:44","subject":"公告本公司決議向金融監督管理委員會申請調降115年第一次現金增資發行價格","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-06-10 19:14，「公告本公司決議向金融監督管理委員會申請調降115年第一次現金增資發行價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7871-2026-06-10-1854-1bjk59k","company_id":"7871","company":"安立璽榮-KY","market":"興櫃","industry":"生技醫療","date":"2026-06-10","time":"18:54:54","subject":"公告本公司2026年(民國115年)股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：安立璽榮-KY（7871），2026-06-10 18:54，「公告本公司2026年(民國115年)股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-06-10-1846-1ineod6","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-06-10","time":"18:46:25","subject":"公告本公司買回庫藏股數量累積達公司已發行股份總額百分之二事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-06-10 18:46，「公告本公司買回庫藏股數量累積達公司已發行股份總額百分之二事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-06-10-1801-1oykchj","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-06-10","time":"18:01:41","subject":"公告本公司受邀參加國票證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-06-10 18:01，「公告本公司受邀參加國票證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-06-10-1736-eu0yb3","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-06-10","time":"17:36:50","subject":"本公司申報資本公積轉增資配發普通股乙案，經金融監督管理委員會退件之說明","clause":"第44款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-06-10 17:36，「本公司申報資本公積轉增資配發普通股乙案，經金融監督管理委員會退件之說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-06-10-1730-1jbvfvt","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"17:30:59","subject":"公告本公司買回股份數量達已發行股份總數百分之二","clause":"第35款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-06-10 17:30，「公告本公司買回股份數量達已發行股份總數百分之二」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-06-10-1717-h11p2r","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-06-10","time":"17:17:40","subject":"公告本公司董事會決議辦理初次上市掛牌前現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-06-10 17:17，「公告本公司董事會決議辦理初次上市掛牌前現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-06-10-1646-65mnt2","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-06-10","time":"16:46:15","subject":"公告本公司董事會決議通過盈餘轉增資發行新股相關事宜","clause":"第31款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-06-10 16:46，「公告本公司董事會決議通過盈餘轉增資發行新股相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-06-10-1641-omddu7","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-06-10","time":"16:41:05","subject":"公告本公司董事轉讓持股超過選任時持股之二分之一，依法其董事職務當然解任","clause":"第6款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-06-10 16:41，「公告本公司董事轉讓持股超過選任時持股之二分之一，依法其董事職務當然解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-06-10-1546-19lxw5b","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-06-10","time":"15:46:20","subject":"本公司受邀參加凱基證券所舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-06-10 15:46，「本公司受邀參加凱基證券所舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-06-10-1535-yhx4s9","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"15:35:34","subject":"公告本公司接獲某國立醫院「全基因定序檢驗試劑套組」標案","clause":"第10款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-06-10 15:35，「公告本公司接獲某國立醫院「全基因定序檢驗試劑套組」標案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-06-10-1532-1v2i6q8","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-06-10","time":"15:32:00","subject":"公告本公司115年5月份自結合併損益","clause":"第53款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-06-10 15:32，「公告本公司115年5月份自結合併損益」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-06-10-1529-v1gwxu","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"15:29:09","subject":"公告本公司調整現金股利配息率","clause":"第14款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-06-10 15:29，「公告本公司調整現金股利配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-06-10-1525-uosge9","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"15:25:23","subject":"本公司受邀參加國票證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-06-10 15:25，「本公司受邀參加國票證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2026-06-10-1514-1feak36","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2026-06-10","time":"15:14:33","subject":"公告本公司115年除息基準日","clause":"第31款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2026-06-10 15:14，「公告本公司115年除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-06-10-1504-zkkjkj","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"15:04:30","subject":"公告本公司董事會決議委任永續發展委員會委員","clause":"第6款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-06-10 15:04，「公告本公司董事會決議委任永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-06-10-1504-1eaiuug","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"15:04:03","subject":"公告本公司董事會決議委任薪資報酬委員會委員","clause":"第6款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-06-10 15:04，「公告本公司董事會決議委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-06-10-1503-1fh57gu","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"15:03:31","subject":"公告本公司審計委員會之委員任期屆滿改選","clause":"第6款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-06-10 15:03，「公告本公司審計委員會之委員任期屆滿改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-06-10-1502-dx1zpf","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"15:02:02","subject":"公告本公司董事長及副董事長續任","clause":"第6款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-06-10 15:02，「公告本公司董事長及副董事長續任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-06-10-1501-19cyjdz","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"15:01:08","subject":"公告本公司115年股東常會同意解除董事及其代表人競業禁止之限制案","clause":"第21款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-06-10 15:01，「公告本公司115年股東常會同意解除董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-06-10-1500-xvmqkh","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"15:00:33","subject":"公告本公司董事當選名單(任期屆滿改選)","clause":"第6款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-06-10 15:00，「公告本公司董事當選名單(任期屆滿改選)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-06-10-1458-1jb8ii5","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"14:58:46","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-06-10 14:58，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-06-10-1441-1jb8ii5","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-06-10","time":"14:41:58","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-06-10 14:41，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4111-2026-06-10-1435-1jb8ii5","company_id":"4111","company":"濟生","market":"上櫃","industry":"生技醫療","date":"2026-06-10","time":"14:35:59","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：濟生（4111），2026-06-10 14:35，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-06-10-1417-12gttc0","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"14:17:16","subject":"本次買回本公司股票累計買回已達已發行股數2%，依規定公告。","clause":"第35款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-06-10 14:17，「本次買回本公司股票累計買回已達已發行股數2%，依規定公告。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-06-10-1412-100esni","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-06-10","time":"14:12:10","subject":"公告本公司研發主管異動","clause":"第8款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-06-10 14:12，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-06-10-1407-1qkz1x4","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"14:07:26","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日","clause":"第14款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-06-10 14:07，「代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-06-10-1407-124ffeh","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-06-10","time":"14:07:03","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利","clause":"第14款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-06-10 14:07，「代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-06-10-0758-54swv6","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-06-10","time":"07:58:11","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-06-10 07:58，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-06-10-0649-3jj0gz","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-06-10","time":"06:49:20","subject":"公告本公司Tofacitinib之美國挑戰專利學名藥(Paragraph IV)申請，通過美國FDA藥證審查，取得審查核可","clause":"第10款","fact_date":"2026-06-09","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-06-10 06:49，「公告本公司Tofacitinib之美國挑戰專利學名藥(Paragraph IV)申請，通過美國FDA藥證審查，取得審查核」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}